Shots:
Recently, Pluri launched its placental allogenic MAIT cell platform for immunotherapy treatment of solid tumors. Mucosal Associated Invariant T (MAIT) cells offer better advantages as compared to conventional T cells
Today, we have with us Efrat Kaduri shedding light on the potential of placental MAIT cells in treating solid tumors
While highlighting the intellectual…
